US 8575165
Methods for treating inflammatory disorders using 2,4-pyrimidinediamine compounds
granted A61KA61K31/506A61P
Quick answer
US patent 8575165 (Methods for treating inflammatory disorders using 2,4-pyrimidinediamine compounds) held by Rigel Pharmaceuticals, Inc. expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Nov 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K31/506, A61P, A61P1/04, A61P11/00